David, Eden http://orcid.org/0000-0001-9666-4132
DePierro, Jonathan M.
Marin, Deborah B.
Sharma, Vanshdeep
Charney, Dennis S.
Katz, Craig L.
Article History
Accepted: 11 September 2021
First Online: 4 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Dr. Dennis Charney is named co-inventor on an issued patent in the United States, and several issued patents outside the U.S. filed by the Icahn School of Medicine at Mount Sinai (ISMMS), for the use of ketamine as a therapy for PTSD. This intellectual property has not been licensed. In addition, Dr. Charney is named co-inventor on several issued U.S. patents, and several pending U.S. patent applications, filed by ISMMS for the use of ketamine as a therapy for treatment-resistant depression and suicidal ideation. ISMMS has entered into a licensing agreement with Janssen Pharmaceuticals, Inc. and it has and will receive payments from Janssen under the license agreement related to these patents. As a co-inventor, Dr. Charney is entitled to a portion of the payments received by the ISMMS. Since SPRAVATO (esketamine) has received regulatory approval for TRD, ISMMS and Dr. Charney as its employee and a co-inventor, will be entitled to additional payments, under the license agreement. Dr. Charney is named co-inventor on a patent application filed by the ISMMS for the use of intranasally administered neuropeptide Y for the treatment of mood and anxiety disorders. This intellectual property has not been licensed. Dr. Charney is a named co-inventor on several patents filed by ISMMS for a cognitive training intervention to treat depression and related psychiatric disorders. ISMMS has entered into a licensing agreement with Click Therapeutics, Inc., and has and will receive payments related to the use of this cognitive training intervention for the treatment of psychiatric disorders. In accordance with the ISMMS Faculty Handbook, Dr. Charney has received a portion of these payments and is entitled to a portion of any additional payments that the medical school might receive from this license with Click Therapeutics. Dr. Craig L. Katz is a paid consultant with Advanced Recovery Systems and the RANE Crisis Network. Eden David and Drs. Jonathan DePierro, Deborah B. Marin, and Vanshdeep Sharma report no financial relationships with commercial interests.
Free to read: This content has been made available to all.